Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence
The Journal of Infectious Diseases · 15.04.2025 · 231 (4) · e638-e649
DOI: 10.1093/infdis/jiaf032 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 22.01.2025. Verfasst von Penelope Gray und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet. Hauptthemen laut MEDLINE: Papillomavirus Infections. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EU project Human Exposome Assessment Platform, ALF, Center for Innovative Medicine (CIIMED.
Abstract (Originalsprache)
Background
Most countries in the world have launched human papillomavirus (HPV) vaccination programs, and declining HPV prevalences are reported. We aimed to disentangle the influences of calendar time, birth cohort, and age by analyzing HPV prevalences in the population-based cervical screening program using age-period-cohort modeling.
Methods
All 813 882 primary HPV-based cervical screening tests from women aged 23–64 years between 2014 and 2023 in the capital region of Sweden were identified in the Swedish National Cervical Screening Registry. The odds ratio (OR) of HPV-16/18 infection was estimated comparing birth cohorts to the unvaccinated 1984-born using an age-period-cohort model. The impact of changing HPV prevalences on the number needed to screen (NNS) to detect and prevent 1 cervical cancer case was calculated.
Results
HPV vaccination coverage was 82%–83% among women born in 1999–2000. Before 2019, the HPV-16/18 prevalence was highest among the youngest women. During 2020–2023 the prevalence consistently decreased among the birth cohorts offered organized school-based vaccination. There was a 98% decline in HPV-16 prevalence (OR, 0.02 [95% confidence interval {CI}, .01–.04]) and a 99% decline in HPV-18 prevalence (OR, 0.01 [95% CI, .00–.04]) among the 2000-born compared to the 1984-born. The declining HPV-16/18 prevalences resulted in major increases in the NNS to detect and to prevent 1 case of cervical cancer.
Conclusions
The declines of HPV-16/18 were considerably larger than the vaccination coverage, suggesting herd immunity. The changing epidemiology of HPV types impacts screening needs, necessitating updated screening programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet.
- Cancer Screening Unit, Regional Cancer Center of Stockholm-Gotland, Stockholm, Sweden.
ORCID-Profile: Penelope Gray, Jiangrong Wang, Sara Nordqvist Kleppe, K Miriam Elfström, Joakim Dillner
Förderung
- EU project Human Exposome Assessment Platform
- ALF
- Center for Innovative Medicine (CIIMED
Zitieren
APA
Gray, P., Wang, J., Nordqvist Kleppe, S., Elfström, K. M., & Dillner, J. (2025). Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence. The Journal of Infectious Diseases, 231(4), e638-e649. https://doi.org/10.1093/infdis/jiaf032
Vancouver
Gray P, Wang J, Nordqvist Kleppe S, Elfström KM, Dillner J. Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence. The Journal of Infectious Diseases. 2025;231(4):e638-e649. doi:10.1093/infdis/jiaf032
BibTeX
@article{Gray2025,
author = {Gray, Penelope and Wang, Jiangrong and Nordqvist Kleppe, Sara and Elfström, K Miriam and Dillner, Joakim},
title = {Population-Based Age-Period-Cohort Analysis of Declining Human Papillomavirus Prevalence},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {4},
pages = {e638--e649},
doi = {10.1093/infdis/jiaf032}
}
EUVIMED